Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

WARNER-LAMBERT NAMES LODEWIJK DE VINK TO HEAD U.S. OPERATIONS

Executive Summary

WARNER-LAMBERT NAMES LODEWIJK DE VINK TO HEAD U.S. OPERATIONS in a "realignment of executive responsibilities" announced March 19. De Vink was previously in charge of international operations. As exec VP and president-U.S. operations, de Vink assumes a role and a title not used since 1985, when the position was occupied by company President/Chief Operating Officer Melvin Goodes. John Walsh succeeds de Vink as president of the international operations. De Vink, 45, now appears to be the number three man at Warner-Lambert. He will report to Goodes and assumes some of Goodes' current duties in his new post. Reporting to de Vink will be Parke-Davis President Joseph Smith, 51, Consumer Health Products Group President Raymond LeFebvre, 51, and American Chicle President Robert Serenbetz, 45. De Vink joined Warner-Lambert in his current post with the international group in 1988, after a long career at Schering-Plough. During his 20 years at Plough he held a variety of marketing and general management positions in the firm's pharmaceutical and consumer products businesses in the U.S., Canada and Europe. De Vink capped his career at Plough as Schering International president from 1986-88. Williams, commenting on de Vink's joining Warner-Lambert in the company's 1988 annual report, said the management team had been "significantly strengthened" by his appointment and highlighted de Vink's "experience and stature." Walsh, 47, has been with Warner-Lambert for 23 years, most recently as president of the Canada/Latin America group. He will report to Goodes. Under Walsh's directions will be Jay Gwynne, president of the Asia/Australia/Capsugel group, and Sam Maugeri, the former Parke-Davis president and now president of the Europe/Middle East/Africa group. Succeeding Walsh as the head of the Canada/Latin America group is Frank Lazo, 42. Lazo, who will also report to Walsh, has been president of the Brazil/Chile/Peru/Uruguay group. A native of Peru, Lazo also has been elected a corporate VP. In a release on the reorganization, Williams suggested the changes were part of a smooth transition of power in preparation for his mandatory retirement in 1991. "These actions," he explained, "are designed to enhance the development and experience base of our senior executives and to help assure the sustained growth of Warner-Lambert in the years to come." The realignment was preceded last March by other executive shifts also designed to pave the way for the succession of Melvin Goodes to chairman ("The Pink Sheet" March 6, 1989, T&G-8). They included the creation of the unit Gwynne directs and Maugeri's move from Parke-Davis.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS017179

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel